Developer Remedy Entertainment is known for cult classics Alan Wake and its more mainstream hits control. nearly a year later Alan Wake II After becoming awards darlings, the studio is making moves on its two supernatural series: bringing them to the silver screen and the small screen.
On Thursday, the studio revealed it was working on a two-tier deal with Annapurna. As part of the partnership, Annapurna has the option of either Allen and control “New entertainment media” including film and television. Annapurna has also committed to bear 50% of Remedy’s development costs Control 2: The studio gets a larger share of the revenue from its games (after recouping costs), while Annapurna will get the majority of the revenue from the eventual adaptation. It doesn’t sound like any Hollywood studios or creative partners have been locked in to spearhead these efforts, but Annapurna CEO Megan Ellison said the deal with Remedy will allow it to “breakthrough in cross-media storytelling.” and the boundaries of experiencing stories”.
At the same time, Remedy CEO Tero Virtala said that this cooperation is an “important milestone” for the developer. While helping Control 2 Annapurna’s involvement helps it self-publish projects of its choice after seeing the light of day. “This…is an exciting opportunity for us,” Virtala added. “We know Annapurna shares our passion for our intellectual property rights and the universe we create. […] Their expertise in film, television and video games made them an ideal partner for us.
Remedy tries to make one Alan Wake The 2018 show was unsuccessful, but this Annapurna deal marks its first attempt control. Due to the game’s expansion, the studio has established that the two series are part of a shared universe. However, this plays out in movies and TV (and which games are adapted into which media), and it’s all in the works at the moment.
Want more io9 news? Check out the latest release dates for Marvel, Star Wars and Star Wars, what’s next for DC Universe movies and TV, and everything you need to know about the future of Doctor Who.
